Publications & Presentations

Publications and Presentations

25 November, 2024

29th Annual Meeting of the Society for Neuro-Oncology

Update on a Potentially Pivotal Trial CNS-201: A Randomized, Controlled Trial of Berubicin vs. Lomustine After First-Line Therapy for Glioblastoma Multiforme (GBM)

By: S. Silberman, Z.Muzyczenko, D.Picker

Berubicin (Recurrent GBM)

26 July, 2024

Pediatric Blood Cancer

A Phase 1 Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma

By: Deanna Mitchell, Genevieve Bergendahl, William Ferguson, William Roberts, et. al.

TPI 287

26 July, 2024

Final Results from the Dose-Escalation Stage of a Phase 1/2 Trial of Tpi 287, a Brain Penetrable Microtubule Inhibitor, Plus Bevacizumab in Patients with Recurrent Glioblastoma

By: S. Goldlust, L. Nabors, III, P. Duin, N. Mobile, T. Benkers, et. al.

TPI 287

26 July, 2024

JAMANeurology

Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome

TPI 287

26 July, 2024

TPI-287, a New Taxane Family Member, Reduces the Brain Metastatic Colonization of Breast Cancer Cells

By: Daniel P. Fitzgerald, David L. Emerson, Yongzhen Qian, et. al.

TPI 287

18 July, 2024

Investor Presentation July 2024

There are no publications that match the selected filters.